apoA2-i

Biomarker

1 paper1 finding

  • Humans1

Associations

1

Intraductal papillary mucinous neoplasm

upin humans1

1 study
  1. apoA2-i predicts intraductal papillary mucinous neoplasm in humans (10.0% vs 4.0%).

    Humansindividuals without pancreatic abnormalities on AUSpancreasn = 70

    Clinical Significance of Additional Imaging in Biomarker-positive Individuals without Pancreatic Abnormalities on Abdominal Ultrasonography: A Comparative Study of Serum Amylase, CA19-9, and apoA2-i

    Health Evaluation and Promotion7 Oct 2026

More on Intraductal papillary mucinous neoplasm

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months